New Formulation Suba-Itraconazole Prophylaxis in Patients with Haematological Malignancy or Undergoing Allogeneic Stem Cell Transplantation

被引：0
|
作者：
Lindsay, Julian [1 ]
Sandaradura, Indy [2 ]
Wong, Kelly [3 ]
Arthur, Christopher [3 ]
Stevenson, William [4 ]
Kerridge, Ian [4 ]
Fay, Keith [3 ]
Coyle, Luke [5 ]
Greenwood, Matthew [3 ]
机构：
[1] Royal North Shore Hosp, Hematol, Sydney, NSW, Australia
[2] St Vincents Hlth Network, Pharmacology, Sydney, NSW, Australia
[3] Royal North Shore Hosp, Dept Haematol, Sydney, NSW, Australia
[4] Univ Sydney, Sydney, NSW, Australia
[5] Royal North Shore Hosp, Haematol, Sydney, NSW, Australia
来源：
BIOLOGY OF BLOOD AND MARROW TRANSPLANTATION | 2018年 / 24卷 / 03期
关键词：
D O I：
暂无
中图分类号：
R5 [内科学];
学科分类号：
1002 ; 100201 ;
摘要：
404
引用
收藏
页码：S284 / S285
页数：2
相关论文
共 50 条
  • [41] Itraconazole vs. fluconazole for antifungal prophylaxis in allogeneic stem-cell transplant patients
    Winston, D. J.
    CLINICAL MICROBIOLOGY AND INFECTION, 2006, 12 : 91 - 96
  • [42] Changing landscapes in haematopoietic stem cell transplantation for haematological malignancy
    Kenyon, M.
    Mufti, G.
    BONE MARROW TRANSPLANTATION, 2009, 43 : S348 - S348
  • [43] Efficacy of prophylaxis with lamivudine in patients undergoing allogeneic stem cell transplantation at risk of hepatis B virus reactivation
    Giaccone, L.
    Festuccia, M.
    Marengo, A.
    Resta, I.
    Sorasio, R.
    Pittaluga, F.
    Fiore, F.
    Boccadoro, M.
    Rizzetto, M.
    Marzano, A.
    Bruno, B.
    BONE MARROW TRANSPLANTATION, 2010, 45 : S37 - S38
  • [44] Efficacy of micafungin in prophylaxis against invasive fungal infections in patients undergoing allogeneic hematopoietic stem cell transplantation
    Hashino, S.
    Kahata, K.
    Onozawa, M.
    Kondo, T.
    Kanamori, H.
    Takahashi, S.
    Asaka, M.
    HAEMATOLOGICA-THE HEMATOLOGY JOURNAL, 2007, 92 : 452 - 452
  • [45] Effective antifungal prophylaxis with Fluconazole and Itraconazole in patients undergoing hematopoetic stem cell transplantation (HSCT): Single centre experience.
    Pivkova, A
    Stojanoski, Z
    Panovska, I
    Krstevska-Balkanov, S
    Cevreska, L
    Efremov, DG
    Georgievski, B
    BLOOD, 2003, 102 (11) : 450B - 450B
  • [46] HAEMATOLOGICAL RECOVERY FROM ALLOGENEIC HAEMATOPOIETIC STEM CELL TRANSPLANTATION
    Ligeiro, Dario
    Abecasis, Manuel
    Lima, Alice
    Miranda, Nuno
    Ferreira, Isabelina
    Teixeira, Gilda
    Trindade, Helder
    TISSUE ANTIGENS, 2013, 81 (05): : 312 - 313
  • [47] Itraconazole-prophylaxis in paediatric allogeneic stem cell transplantation leads to decreased frequency of empiric antifungal therapy
    Schuster, F
    Albert, M
    Führer, M
    Liese, J
    Beiohradsky, BH
    Borkhardt, A
    BONE MARROW TRANSPLANTATION, 2005, 35 : S182 - S183
  • [48] MICAFUNGIN FOR ANTIFUNGAL PROPHYLAXIS IN PATIENTS UNDERGOING AUTOLOGOUS STEM CELL TRANSPLANTATION
    Sierra, P.
    Torres, F.
    Quesada, M.
    Lopez, J.
    Huerta, J.
    Nieto, S.
    Munoz, A.
    HAEMATOLOGICA, 2013, 98 : 726 - 726
  • [49] A disease risk index for patients undergoing allogeneic stem cell transplantation
    Armand, Philippe
    Gibson, Christopher J.
    Cutler, Corey
    Ho, Vincent T.
    Koreth, John
    Alyea, Edwin P.
    Ritz, Jerome
    Sorror, Mohamed L.
    Lee, Stephanie J.
    Deeg, H. Joachim
    Storer, Barry E.
    Appelbaum, Frederick R.
    Antin, Joseph H.
    Soiffer, Robert J.
    Kim, Haesook T.
    BLOOD, 2012, 120 (04) : 905 - 913
  • [50] Prevention of mucositis with KGF in patients undergoing allogeneic stem cell transplantation
    Goldberg, J. D.
    Zheng, J.
    Castro-Malaspina, H.
    Jakubowski, A. A.
    Heller, G.
    Van den Brink, M. R. M.
    Perales, M.
    JOURNAL OF CLINICAL ONCOLOGY, 2011, 29 (15)
12345